See also this year's filing and all EDGAR filings for this company.
PDF Report 0001597264_2022_Blueprint_Medicines_Corp.pdf
Logs
Graph
Absolute values for 0001597264, Blueprint Medicines Corp
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 554,025,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 30,700,000 |
| 3 | remainder_Assets | 667,500,000 |
| 4 | LiabilitiesCurrent | 149,765,000 |
| 5 | LiabilitiesNoncurrent | 131,725,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 17,934,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 195,293,000 |
| 9 | ResearchAndDevelopmentExpense | 601,033,000 |
| 10 | remainder_Expenses | 10,802,000 |
| 11 | remainder_Revenues | 180,080,000 |
| 12 | remainder_NetIncome | 897,000 |
| 13 | remainder_ComprehensiveNetIncome | 1,081,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 1,252,225,000 |
| 1 | Liabilities | 281,490,000 |
| 2 | Expenses | 825,062,000 |
| 3 | Revenues | 180,080,000 |
| 4 | StockholdersEquity | 970,735,000 |
| 5 | NetIncome | -644,085,000 |
| 6 | ComprehensiveNetIncome | -643,544,500 |
| 7 | BaseVar | 1,270,417,500 |
| 8 | EconomicCapitalRatio | 1.34 |
Edgar->Model Mapping
Feature Distribution
Change over Time
